News
05/09/23
Opin.AI Breaks Down Barriers in Clinical Trial Participation
17/01/23
2023 Prepped and Primed: Opyl (ASX:OPL) with CEO, Michelle Gallaher
07/12/22
Year in Review: Opyl (ASX:OPL) with CEO, Michelle Gallaher
07/11/22
Big data could cure cancer
21/10/22
Opyl’s TrialKey achieves major milestone with potential to improve clinical trial success rates
30/09/22
Improving clinical trials with AI. Michelle Gallaher, Opyl.
28/09/22
Opyl tips revenue growth from partnership with Consentic and its newly launched screening services
16/09/22
Opyl appoints news chairman as it eyes international growth
08/09/22
ANDHealth Summit 2022 – Technology as a Therapy
01/09/22
Opyl prepares to launch Opin into the global $4.7 billion clinical trial recruitment market
29/07/22
ASX Quarterlies: Tech powers ahead in strong finish to reporting week
07/07/22